10/30/2017 6:00:53 PM - Slumped to a close below its 50 DMA line ($41.23) today raising concerns. Only a prompt rebound would help its outlook improve. Prior highs in the $41 area may act as support. Its Relative Strength rating has slumped to 72, below the 80+ minimum guideline for buy candidates. Recently reported Sep '17 earnings +7% on +44% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. It will be dropped from the Featured Stocks list tonight.
10/25/2017 5:23:28 PM - G - Gapped down today and undercut its 50 DMA line then found prompt support and managed a "positive reversal". Prior highs and its 50 DMA line define support in the $41 area. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
10/17/2017 5:25:23 PM - G - Volume totals have been cooling while stubbornly holding its ground near its 52-week high following an impressive spurt of volume-driven gains. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
10/12/2017 5:06:45 PM - G - Still stubbornly holding its ground near its 52-week high following an impressive spurt of volume-driven gains. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and a new annotated graph.
10/10/2017 5:53:12 PM - G - Stubbornly holding its ground at its 52-week high following to an impressive spurt of volume-driven gains. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
10/3/2017 11:41:02 AM - G - Perched at its 52-week high following to an impressive spurt of volume-driven gains. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/27/2017 5:27:12 PM - G - Hit another new 52-week high with today's 4th consecutive gain adding to an impressive spurt of volume-driven gains. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/26/2017 12:44:24 PM - G - Hitting a new 52-week high with today's gain adding to a recent spurt of volume-driven gains. Relative Strength rating is currently 81, above the 80+ minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/25/2017 12:31:03 PM - G - Trading above its 50 DMA line ($39.80) and still perched near its 52-week high. Relative Strength rating is currently 79, just below the 80+ minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/22/2017 12:25:08 PM - G - Trading above its 50 DMA line ($39.79) and its Relative Strength rating is currently 81, above the minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/18/2017 12:22:15 PM - G - Consolidating in a tight range near its 50 DMA line ($39.79). Its Relative Strength rating is currently 75, below the minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and an annotated graph.
9/15/2017 12:47:38 PM - G - Consolidating in a tight range near its 50 DMA line ($39.80). Its Relative Strength rating is currently 75, below the minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and an annotated graph.
9/14/2017 5:26:45 PM - G - Consolidating in a tight range near its 50 DMA line ($39.80). Its Relative Strength rating is currently 75, below the minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and a new annotated graph.
9/13/2017 2:02:33 PM - G - Consolidating in a tight range near its 50 DMA line ($39.81). Its Relative Strength rating is currently 80, right at the minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/12/2017 12:48:36 PM - G - Consolidating in a tight range near its 50 DMA line ($39.84). Its Relative Strength rating is currently 79, just below the 80+ minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
9/7/2017 1:29:56 PM - G - Consolidating in a tight range, but it has slumped below its 50 DMA line ($39.84) and its Relative Strength rating has slipped to 77, below the 80+ minimum guideline for buy candidates. Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
8/31/2017 2:43:12 PM - G - Consolidating in a tight range near its 50 DMA line ($39.78). Recently reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
8/25/2017 2:25:33 PM - G - Rebounded above its 50 DMA line ($39.70) this week, helping its technical stance and outlook improve. Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
8/17/2017 12:11:58 PM - G - Slumped further below its 50 DMA line ($39.60) and its color code was changed to green. Early weakness undercut the recent low ($38.75 on 7/20/17) raising concerns and triggering a more worrisome technical sell signal. Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and an annotated graph.
8/17/2017 11:09:28 AM - G - Slumping further below its 50 DMA line ($39.60) and its color code is changed to green after violating the recent low ($38.75 on 7/20/17) raising concerns and triggering a more worrisome technical sell signal. Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and a new annotated graph.
8/16/2017 5:10:12 PM - Y - Consolidating in a tight range near its 50 DMA line ($39.60). Subsequent damaging losses violating the recent low ($38.75 on 7/20/17) would trigger a worrisome technical sell signal. Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. See the latest FSU analysis for more details and a new annotated graph.
8/11/2017 5:57:06 PM - Y - Still consolidating near its 50 DMA line ($39.52). Subsequent damaging losses violating it or the recent lows would trigger technical sell signals. Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
8/4/2017 5:33:26 PM - Y - Consolidating above support at its 50 DMA line ($39.30). Subsequent damaging losses violating it or the recent lows would trigger technical sell signals. Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns.
7/31/2017 5:48:24 PM - Y - Reported Jun '17 earnings +23% on +45% sales revenues, below the +25% minimum earnings guideline (C criteria), raising fundamental concerns. Found support at its 50 DMA line ($39.13) recently and any damaging losses violating it or the recent lows would trigger technical sell signals.
7/24/2017 2:46:56 PM - Y - Due to report Jun '17 earnings news after the market closes on Tuesday, July 25, 2017, and volume and volatility often increase near earnings news. Found support at its 50 DMA line ($38.90) recently and any damaging losses violating it or the recent lows would trigger technical sell signals.
7/20/2017 5:40:51 PM - Y - Managed a "positive reversal" today and closed at the session high after testing support at its 50 DMA line ($38.85). Any damaging losses violating its 50 DMA line and recent lows would trigger technical sell signals.
7/14/2017 3:26:03 PM - Y - Stubbornly holding its ground since hitting a new 52-week high with a gain on 7/04/17 backed by average volume. Its 50 DMA line ($38.82) and recent lows define near-term support in the $37-38 area.
7/10/2017 5:46:00 PM - Y - Holding its ground since hitting a new 52-week high with a gain on 7/04/17 backed by average volume. Its 50 DMA line and recent lows define near-term support in the $37-38 area. See the latest FSU analysis for more details and a new annotated graph.
7/3/2017 1:07:03 PM - Y - Posted a big gain today with volume running at an above average pace while hitting a new 52-week high, triggering a technical buy signal. Its 50 DMA line and recent lows define near-term support in the $37-38 area.
6/27/2017 6:11:53 PM - Y - Posted a gain today with near average volume, rising within close striking distance of its 52-week high. Its 50 DMA line and recent lows define near-term support in the $37-38 area. Subsequent gains above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal. Prior lows in the $36-35 area define the next important support level.
6/21/2017 2:00:01 PM - Y - Still perched within close striking distance of its 52-week high and consolidating above its 50 DMA line ($38.17). Subsequent gains above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal. Prior lows in the $36-35 area define the next important support level.
6/14/2017 11:41:11 AM - Y - Color code is changed to yellow while perched within close striking distance of its 52-week high and consolidating above its 50 DMA line ($37.95). Subsequent gains above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal. Prior lows in the $36-35 area define the next important support level.
6/7/2017 1:45:12 PM - G - Pulling back from from its 52-week high and undercutting its 50 DMA line ($37.77) today raising concerns and its color code is changed to green. Prior lows in the $36-35 area define the next important support level.
6/5/2017 2:36:51 PM - Y - Gapped up today nearly challenging its 52-week high and approaching its pivot point. A volume-driven gain for new highs may trigger a technical buy signal. Its 50 DMA line ($37.74) defines support above prior lows in the $35 area
5/30/2017 5:37:15 PM - Y - Quietly consolidating near its 50 DMA line ($37.53). Prior lows in the $35 area define the next important chart support level to watch. See the latest FSU analysis for more details and a new annotated graph.
5/24/2017 10:58:51 AM - Y - Found support while consolidating near its 50 DMA line ($37.47) and its color code is changed to yellow. Prior lows in the $35 area define the next important chart support level to watch. Subsequent gains above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal.
5/18/2017 7:32:53 PM - G - Color code is changed to green after slumping to a close below its 50 DMA line ($37.37). Prior lows in the $35 area define the next important chart support level to watch. A subsequent rebound above the 50 DMA line gain and rally above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal.
5/12/2017 2:22:05 PM - Y - Pulling back near its 50 DMA line ($37.33) defining near-term support. Volume totals have been cooling while consolidating within close striking distance of its 52-week high. A gain above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal.
5/8/2017 10:15:36 AM - Y - Volume totals have been cooling while consolidating within close striking distance of its 52-week high. A gain above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal.
5/1/2017 8:17:25 PM - Y - Still perched near its 52-week high. A gain above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal.
4/26/2017 5:00:53 PM - Y - Touched a new 52-week high with above average volume behind today's 3rd consecutive gain. It finished strong after highlighted in yellow in the 4/25/17 mid-day report with new pivot point cited based on its 1/27/17 high plus 10 cents. A gain above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal. Up from its $20 IPO on 3/19/15. Reported Mar '17 earnings +32% on +42% sales revenues extending its streak to 9 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria). See the latest FSU analysis for more details and an annotated graph.
4/26/2017 1:25:34 PM - Y - Hitting a new 52-week high with today's 3rd consecutive gain. Finished strong after highlighted in yellow in the 4/25/17 mid-day report with new pivot point cited based on its 1/27/17 high plus 10 cents. A gain above the pivot point backed by a minimum of +40% above average volume may trigger a technical buy signal. Up from its $20 IPO on 3/19/15. Reported Mar '17 earnings +32% on +42% sales revenues extending its streak to 9 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria).
4/25/2017 7:13:02 PM - Y - Finished strong after highlighted in yellow in the mid-day report with new pivot point cited based on its 1/27/17 high plus 10 cents. A volume-driven gain for a new 52-week high is needed to trigger a technical buy signal. Up from its $20 IPO on 3/19/15. Reported Mar '17 earnings +32% on +42% sales revenues extending its streak to 9 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria).
4/25/2017 12:54:27 PM - Y - Color code is changed to yellow with new pivot point cited based on its 1/27/17 high plus 10 cents. A volume-driven gain for a new 52-week high is needed to trigger a technical buy signal. Up from its $20 IPO on 3/19/15. Reported Mar '17 earnings +32% on +42% sales revenues extending its streak to 9 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria).
4/3/2017 12:02:43 PM - Retreated back below its 50 DMA line. Up from its $20 IPO on 3/19/15. Reported Dec '16 earnings +57% on +21% sales revenues extending its streak to 8 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria).
3/30/2017 1:03:43 PM - Rebounded above its 50 DMA line helping its outlook to improve. Up from its $20 IPO on 3/19/15. Reported Dec '16 earnings +57% on +21% sales revenues extending its streak to 8 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria).
3/27/2017 12:23:48 PM - Failing to rebound after violating its 50 DMA line ($37.11), and a rebound above that short-term average is needed for its outlook to improve. Prior mid-day reports noted - "Up from its $20 IPO on 3/19/15. Reported Dec '16 earnings +57% on +21% sales revenues extending its streak to 8 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria)."
3/14/2017 12:48:31 PM - Failing to rebound after violating its 50 DMA line ($37.16), and a rebound above that short-term average is needed for its outlook to improve. The 3/10/17 mid-day report noted - "Up from its $20 IPO on 3/19/15. Reported Dec '16 earnings +57% on +21% sales revenues extending its streak to 8 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria)."
3/10/2017 12:38:22 PM - Slumping below its 50 DMA line. Up from its $20 IPO on 3/19/15. Reported Dec '16 earnings +57% on +21% sales revenues extending its streak to 8 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria).
1/13/2017 12:24:53 PM - Reported Sep '16 earnings +65% on +45% sales revenues extending its streak to 7 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria). It is very extended from any sound base after rallying from support at its 50 DMA line when noted in the 10/25/16 mid-day report - "Up from its $20 IPO on 3/19/15, it has a limited and choppy history."
1/5/2017 12:56:20 PM - Reported Sep '16 earnings +65% on +45% sales revenues extending its streak to 7 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria). It is very extended from any sound base after rallying from support at its 50 DMA line when noted in the 10/25/16 mid-day report - "Up from its $20 IPO on 3/19/15, it has a limited and choppy history."
12/9/2016 12:32:14 PM - Reported Sep '16 earnings +65% on +45% sales revenues extending its streak to 7 consecutive quarterly comparisons with earnings increasing above the +25% minimum guideline (C criteria). Extended from any sound base after rallying from support at its 50 DMA line when last noted in the 10/25/16 mid-day report - "Up from its $20 IPO on 3/19/15, it has a limited and choppy history."
10/25/2016 12:36:23 PM - Due to report Sep '16 earnings news after the close today. Consolidating near its 50 DMA line. Last noted with caution in the 9/15/16 mid-day report - "Up from its $20 IPO on 3/19/15, it has a limited and choppy history. Reported earnings +63% on +46% sales revenues for the Jun '16 quarter, extending its streak to 6 consecutive quarterly comparisons with earning increasing above the +25% minimum guideline (C criteria)."
9/15/2016 12:19:08 PM - Perched within striking distance of its 52-week high following 7 consecutive weekly gain. Up from its $20 IPO on 3/19/15, it has a limited and choppy history. Reported earnings +63% on +46% sales revenues for the Jun '16 quarter, extending its streak to 6 consecutive quarterly comparisons with earning increasing above the +25% minimum guideline (C criteria).
9/8/2016 12:31:42 PM - Perched within striking distance of its 52-week high while on track for a 7th consecutive weekly gain. Up from its $20 IPO on 3/19/15, it has a limited and choppy history. Reported earnings +63% on +46% sales revenues for the Jun '16 quarter, extending its streak to 6 consecutive quarterly comparisons with earning increasing above the +25% minimum guideline (C criteria).
12/7/2015 12:48:28 PM - Consolidating after a "negative reversal" when last noted with caution in the 11/20/15 mid-day report - "Reversed into the red after early gains today challenging its 52-week high. Reported earnings +63% on +68% sales revenues for the Sep '15 quarter, it 3rd consecutive quarterly comparison with earning increasing above the +25% minimum guideline (C criteria). Up from its $20 IPO on 3/19/15, its limited and choppy history is a concern."
11/20/2015 12:29:40 PM - Reversed into the red after early gains today challenging its 52-week high. Reported earnings +63% on +68% sales revenues for the Sep '15 quarter, it 3rd consecutive quarterly comparison with earning increasing above the +25% minimum guideline (C criteria). Up from its $20 IPO on 3/19/15, its limited and choppy history is a concern.
5/29/2015 12:34:31 PM - Holding its ground near its 52-week high. Up from its $20 IPO on 3/19/15, and its limited history is a concern. Reported earnings +82% on +94% sales revenues for the Mar '15 quarter, but fundamental concerns remain. Prior quarterly comparisons did not show strong and steady earning increases above the +25% minimum guideline (C criteria).